NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Avanza Capital Holdings, a trailblazer in the alternative finance and ...
Abstract Title: Biomarker analysis from Phase 2 study of AgenT-797 (invariant natural killer T-cells), botensilimab (a Fc-enhanced CTLA-4 Inhibitor) with balstilimab (anti-PD-1) in PD-1 refractory ...
DNA Health & Wellness, the UAE's leading health optimisation and longevity clinic group, is thrilled to announce the grand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results